Excombi 5/160 mg

Adult dose

The recommended dose of this medication is one tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning).

Child dose

The safety and efficacy of this drug for pediatric patients under 18 years of age have not been established, and its use is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be stopped immediately if pregnancy is confirmed. This medication should not be used in individuals who are allergic to the active ingredients or similar drugs, women who are pregnant or breastfeeding, and patients with severe kidney or liver diseases. Patients who are low in sodium or fluids may experience low blood pressure, so their condition should be checked before administration, and if symptoms of low blood pressure occur, they should lie down and rest immediately. Patients with high potassium levels must be cautious when taking this drug and potassium supplements or medications that may increase potassium, and should have their serum potassium levels frequently monitored. Patients with vascular issues in the kidneys or those who have received a kidney transplant require close monitoring as this medication may affect kidney function. If symptoms of angioedema (swelling of the face, lips, tongue, etc.) occur during treatment, discontinue the medication immediately and do not resume. Patients with heart failure or following myocardial infarction should be observed closely for any changes in kidney function while taking this medication, and patients with acute myocardial infarction should be careful as angina or myocardial infarction may worsen during treatment with this drug. The dose for patients with weak liver function should be limited, and it should not be used in patients with severe liver disease. Caution is advised as dizziness or fatigue may occur when driving or operating machinery. This medication may interact with other antihypertensives, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is essential to inform your doctor or pharmacist if there are any other medications being taken. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid it. This medication is not recommended for patients under 18 years of age as its safety and efficacy have not been established. In the elderly, it can be administered at doses similar to those for general adults, but their condition should be carefully monitored. In case of overdose, low blood pressure, dizziness, and in severe cases, shock may occur, so immediate medical attention is required.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), a very tired feeling throughout the body, sudden and very severe headaches, lightning headaches, seizures, confusion, visual disturbances, paralysis, urination difficulties

Mild side effects

• Headache
• dizziness
• drowsiness
• sensory disturbance
• lightheadedness
• tinnitus
• tachycardia
• palpitations
• orthostatic hypotension
• hypotension

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and should be kept at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication.

Appearance

Dark yellow oval film-coated tablets

Package unit

Domestic: 30 tablets (10 tablets/PTP X 3), Export: 30 tablets (10 tablets/PTP X 3)